Zhejiang Xianju Pharmaceutical Co.,Ltd. (SHE:002332)

Market Cap	9.28B
Revenue (ttm)	3.97B
Net Income (ttm)	390.04M
Shares Out	989.20M
EPS (ttm)	0.39
PE Ratio	23.88
Forward PE	15.07
Dividend	0.30 (3.20%)
Ex-Dividend Date	May 28, 2025

Volume	8,897,114
Average Volume	12,449,886
Open	9.28
Previous Close	9.37
Day's Range	9.28 - 9.45
52-Week Range	8.60 - 14.80
Beta	0.21
RSI	50.82
Earnings Date	Aug 27, 2025

About SHE:002332

Zhejiang Xianju Pharmaceutical Co.,Ltd. manufactures and sells steroids and hormones worldwide. The company offers gynecological, anesthesia, respiratory, dermatology, generic drug, and other products; and active pharmaceutical ingredients (API), such as corticosteroids, sex hormone, progesterone, non-hormone series, newchem API, and intermediates products. The company was founded in 1972 and is headquartered in Xianju, China.

• Industry: Drug Manufacturers - Specialty & Generic
• Sector: Healthcare
• Founded: 1972
• Employees: 3,205
• Stock Exchange: Shenzhen Stock Exchange
• Ticker Symbol: 002332

Financial Performance

In 2024, SHE:002332's revenue was 4.00 billion, a decrease of -2.98% compared to the previous year's 4.12 billion. Earnings were 397.18 million, a decrease of -29.46%.